fda status bpc 157 tb 500 fda warning unapproved peptide products bpc-157 tb-500 BPC-157 BPC-157/TB-500 Capsules | Starts at
Description
Invest in your health and feel the difference
According to the randomization procedure, Group 1 was assigned to the novel methylcobalamin nasal spray (NASO B12) and Group 2 was assigned to methylcobalamin oral tablet for the treatment of vitamin B12 deficiency during the study period of 15 days [Figure 1]
For details see the Supplemental Methods
If the condition is not treated early, long-term effects will occur on the body
doi: 10.3390/cells11020307
If your symptoms ever get worse instead of better during your after-care, consult a doctor
